Breast Cancer

Latest News


Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Breast Cancer Guideline Updates: ASCO 2024

An oncology expert shares advances in breast cancer management, with insights on the growing role of CDK4/6 inhibitors, updates to NCCN guidelines, and anticipated research findings at ASCO 2024

Breast Cancer Guideline Updates: ASCO 2024

The American Journal of Managed Care

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

The American Journal of Managed Care

Latest Videos


CME Content


More News

What we’re reading, October 13, 2016: researchers, Alzheimer’s patients, and their families anxiously await the results of a clinical trial that could help slow the disease’s progress; many breast cancers detected by mammograms are overtreated even though they likely would not be fatal on their own; stock prices fall for Humana and Cigna as CMS says a minority of their patients are in plans rated 4 stars or higher.

This study tested 3 financial incentives encouraging breast cancer screening (mammograms) among women deemed overdue. None were effective overall; "person-centered" incentives worked in the most recently screened subgroup.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo